Bio News

GC MediAI has launched Uisarang AI, an AI-powered clinical solution based on Uisarang, the electronic medical record with the largest market share in South Korea. To mark the launch, GC MediAI will provide all features free of charge through the end of 2026. The company plans to combine Uisarang AI with its cloud EMR, scheduled for release next year.

BIOBOOK TEAM
biobookmedia@biobook.co.krCurexo Posts 54.5 Billion Won in Cumulative Third-Quarter Revenue; Medical Robotics Loss Widens
Kolon TissueGene Posts 73.3 Billion Won in Net Income Through Q3, Returns to Profit
LabGenomics’ Third-Quarter Operating Loss Narrows by Half to KRW 14.5 Billion Year Over Year
Regeneron’s POTS drug succeeds in Phase 2; Phase 3 to begin in first half of next year
NGeneBio’s Cumulative Revenue Through Q3 Reaches KRW 37.8 Billion, Up 308% Year Over Year
Inventera Successfully Completes Phase 3 Trial of Joint Contrast Agent INV-002 in South Korea